Showing results (1431-1440 of 1,450) with videos related to
Sort By:
Pageof 145
Nature Cardiovascular Research|July 3, 2026
Depth of neutrophil mobilization stratifies survival in ST-elevation myocardial infarctionMathis Richter, Jessica von Göwels, Maximilian Fähndrich, et al.BMC Psychiatry|November 12, 2010
The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patientsKatja Ribbe, Heidi Friedrichs, Martin Begemann, et al.Journal of the American Medical Informatics Association : JAMIA|February 24, 2023
Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational studyAnna Ostropolets, Yasser Albogami, Mitchell Conover, et al.International Journal of Cardiology|June 3, 2017
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapyGerhard Pölzl, Johann Altenberger, Loant Baholli, et al.Pharmacopsychiatry|July 2, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspectsXenia M Hart, Gerhard Gründer, Christoph Hiemke, et al.Nature Genetics|October 3, 2006
Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmusPatrick Tarpey, Shery Thomas, Nagini Sarvananthan, et al.Science (New York, N.Y.)|December 2, 2017
The target landscape of clinical kinase drugsSusan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm, et al.Journal of Cardiovascular Pharmacology|July 9, 2020
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.Acta Neuropathologica|October 14, 2024
Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathyEllen Gelpi, Raphael Reinecke, Carles Gaig, et al.Cardiac Failure Review|July 28, 2020
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.Pageof 145